[Siderosis of the brain and spinal cord. Report of two cases]. / Sidérose cérébrale et médullaire. A propos de deux observations.

Two cases of superficial siderosis of the brain and spinal cord with cochleovestibular and cerebellar symptoms are diagnosed on brain and spinal MRI scans. Low signal intensity lines are noted on the surface of the brainstem, cerebellum, spinal cord and within the interhemispheric and sylvian fissures. In one case, no brain or vascular malformation is identified; in the second case, two cavernous angiomas are noted on the MRI study. 3D CISS may visualize thickening of the cochleovestibular nerve.

Inhalation of aerosolized vitamin a: reversibility of metaplasia and dysplasia of human respiratory epithelia -- a prospective pilot study.

The objective of this preliminary uncontrolled study was twofold: First, to assess the feasibility of retinyl palmitate inhalation and second, to analyze the changes of metaplastic lesions of the respiratory epithelium (metaplasia or dysplasia) following retinyl palmitate inhalation. The response to a daily dose of 18.000 I.U. retinyl palmitate by inhalation over a period of 3 month was assessed in 11 subjects (9 smokers, 2 ex-smokers). Using white-light bronchoscopy combined with autofluorescence bronchoscopy, bronchial biopsies were taken before and after a 3 month-period. The biopsy samples were evaluated blind by a referee lung pathologist. The overall response rate (remission or partial remission) was 56% (95% CI 0.30 0.79; p<0.05). These data suggest that inhalation of retinyl esters could be a promising therapeutical approach for chemoprevention of lung cancer. Vitamin A; chemoprevention; lung cancer; squamous metaplasia; dysplasia; retinoids

Critical review of the epidemiology literature on the potential cancer risks of methylene chloride.

OBJECTIVE: To critically review and summarize the epidemiological evidence published to date on the carcinogenicity of methylene chloride to humans. METHODS: Papers for review were identified through Medline (National Library of Medicine) and were limited to epidemiology studies. Studies were classified using three categories. Primary studies focused on the association between methylene chloride and cancer among occupational cohorts primarily exposed to methylene chloride. Secondary studies identified methylene chloride a priori as a potential exposure of interest, and the investigators either characterized the methylene chloride exposure or described results for the methylene chloride-exposed workers separately. Tertiary studies evaluated cohorts either minimally exposed to methylene chloride or presumed exposed but for which no exposure estimation or separate classification was made. RESULTS: No strong or consistent finding for any site of cancer was apparent despite several studies of large occupational cohorts of workers potentially exposed to high concentrations of methylene chloride. Sporadic and weak associations were reported for cancers of the pancreas, liver and biliary passages, breast, and brain. Although these studies collectively cannot rule out the possibility of any cancer risk associated with methylene chloride exposure, they do support a conclusion of no substantive cancer risk. CONCLUSIONS: Continued follow-up of the established cohorts may elucidate the few and inconsistent relationships reported to date; however, it appears likely that risks associated with methylene chloride exposure, if any, are small and limited to rare cancers. The usefulness of additional cohort studies for the evaluation of cancer risks associated with methylene chloride exposure will depend largely on whether the relevant exposure period has passed and whether exposure characterization (e.g., peak or intermittent exposure or intensity) can be improved.

Efficacy of moxidectin against nematodes in naturally infected sheep.

The activity of an oral drench of moxidectin against nematodes in naturally infected sheep known to harbour Nematodirus species was evaluated at doses of 0.2 and 0.4 mg/kg bodyweight. Moxidectin was 100 per cent effective against nematodes in the abomasum and 100 per cent effective against nematodes in the small intestine except for adult Trichostrongylus species, against which its efficacy was 94 per cent. It was 100 per cent effective against nematodes in the large intestine except for Trichuris ovis, against which its efficacy was 83 per cent.

[Secondary data analysis within the scope of occupational medicine epidemiology]. / Sekundärdatenanalyse im Rahmen der arbeitsmedizinischen Epidemiologie.

The analysis of large administrative data sets plays an important rôle in occupational epidemiology in Germany. In this article, examples of such data sets and their use in epidemiologic investigations are presented. The validity of administrative data is discussed.

A review of epidemiological methods applied in studies on laboratory animal allergy. With a discussion of the relation between prevalence and risk of an irreversible disease in a dynamic population of constant size.

The risk of developing an occupational allergic respiratory disease depends strongly on the duration of exposure. For estimating the instantaneous risk (hazard function) in a dynamic cohort, information is required for each cohort member on the time of exposure either until disease onset or until termination by leaving the job or the end of the study. However, most existing epidemiological studies on occupational allergies are cross-sectional, computing prevalences; no information on job-leavers and on their disease status is obtained. The functional dependency of prevalence on risk, as well as on the rate of leaving the job among the diseased and on the distribution of exposure duration, is described, with special attention to the sensitivity of the prevalence to differences of the rate of leaving the job. A literature review of 15 studies on laboratory animal allergy is given; none of the studies collected and reported all the information necessary for risk estimation.

Immunity to Heligmosomoides polygyrus induced by subcutaneous vaccination with post-infection larvae.

The objective of this study was to investigate, using the Heligmosomoides polygyrus (= Nematospiroides dubius)-mouse model, whether live post-infection trichostrongylid larvae recovered from the intestinal wall of donor animals and placed subcutaneously would serve as vaccine protecting against oral challenge by third-stage (infective) larvae (L3). Experiments were conducted to determine the effect of number and age of post-infective larvae as well as age and sex of host on vaccination. Vaccinated BALB/cByJ mice were challenged with 30 L3 and total adult worm burdens compared between vaccinated groups and sham-treated controls (greater than 90% infection rates). All mice subcutaneously vaccinated with either five or 10 larvae harbored significantly fewer challenge parasites in their intestines than did sham-treated controls (P less than 0.001). Both young and mature mice were significantly protected against challenge by the subcutaneous larval vaccine. Adult female mice had significantly (P less than 0.05) fewer parasites than adult male mice. The age of the larvae (indicated as the days between infection and harvesting of the larvae) was important in that day-4 or day-6 larvae (L4) were significantly more protective (P less than 0.001) than day-2 (L3) or day-8 larvae (L5-preadult). Reduction in worm burden for young vaccinated animals ranged from 31 to 39% (P less than 0.001) and for mature animals from 88 to 100% (P less than 0.001). Passive transfer to serum resulted in the reduction of worm burdens by 26-40% (P less than 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)

Function and lifespan of corpora lutea in ewes treated with exogenous oxytocin.

Oxytocin was administered to Dorset and Shropshire ewes in one experiment and to Dorset ewes in a further 4 experiments. In Exp. 1, concentrations of plasma progesterone and lengths of the oestrous cycle in ewes given oxytocin subcutaneously twice a day on Days 0-3, 2-5, 4-7, 6-9, 8-11, 10-13, 12-15 or 14-17 were similar to those of control ewes. In Exp. 2, intraluteal infusions of oxytocin from Day 2 to Day 9 after oestrus had no effect on concentration of progesterone, weight of CL collected on Day 9 or length of the oestrous cycle. In Exp. 3, intraluteal infusions of oxytocin on Days 10-15 after oestrus had no effect on weight of CL collected on Day 15. In Exp. 4, s.c. injections of oxytocin on Days 3-6 after oestrus had no effect on weight of CL collected on Day 9, concentrations of progesterone or length of the oestrous cycle. In Exp. 5, s.c. injections of oxytocin twice a day did not affect the maintenance and outcome of pregnancy in lactating and nonlactating ewes. Exogenous oxytocin, therefore, does not appear to affect luteal function at any stage of the ovine oestrous cycle although oxytocin has been reported by others to alter ovine CL function.

Comparison of two progestogens during out-of-season breeding in a commercial ewe flock.

A comparison was made of the relative effectiveness of subcutaneous ear implants containing 2 mg Norgestomet or vaginal pessaries containing 60 mg medroxyprogesterone acetate (MAP) to induce estrus and conception in dry anestrous ewes. Groups of ewes were treated with one of the two progestogens for 14 d, and 500 IU pregnant mare serum gonadotropin (PMSG) was administered intramuscularly at the time of progestogen withdrawal. No significant differences in estrus induction, pregnancy rate or number of lambs born per ewe lambing were observed. Ewes treated with Norgestomet had 96% estrus, 60% pregnancy rate and 1.4 lambs per ewe lambing. Comparably, ewes treated with MAP had 94% estrus, 65% pregnancy rate and 1.7 lambs per ewe lambing. Norgestomet implants compared favorably with MAP pessaries for estrus induction and breeding of commercial, dry anestrous ewes.

Toxicity and tissue residue depletion of levamisole hydrochloride in young goats.

Toxicity and tissue residue depletion studies were conducted in young goats, using an oral drench formulation of levamisole hydrochloride. In the target animal toxicity study, 3 groups of 5 goats each were given levamisole orally to provide approximately 11.88, 23.76, or 35.64 mg of levamisole HCl/kg/d for 3 consecutive days; a fourth group of 5 goats served as untreated controls. Blood samples were taken for analysis of levamisole 1 day prior to dosing and 1, 2, 3, 4, and 7 days following the third dose. At the 35.64-mg/kg dose, 2 of 5 goats responded with typical cholinergic signs of toxicosis on each of the 3 days of dosing. The times for the onset of clinical signs of toxicosis ranged from 18 to 63 minutes, with an average duration of 32 minutes. Administration of 23.76 mg of levamisole HCl/kg resulted in hyperactive behavior in 1 of 5 goats only on the first day of dosing; no abnormal behavior was observed in any of the 5 goats following the second or third dose of levamisole HCl at 23.76 mg/kg. Untoward effects were not seen in the 5 goats dosed at 11.88 mg of levamisole HCl/kg or in the controls during the 3-day dosing period or in the following 7-day observation period. Overall, the observed signs of toxicosis did not become more severe, affect more goats, or persist for a longer period on subsequent dosing days.(ABSTRACT TRUNCATED AT 250 WORDS)

Utilization of screening mammography by primary care physicians.

Although mammography is the primary modality for the detection of early breast cancer, routine screening of asymptomatic women in the U.S. has not occurred. A survey of the referral practices for breast cancer screening of 513 Virginia primary care physicians was conducted. An average percentage of 39% of women age 35 to 40, 55% of women age 40 to 50, and 57% of women over age 50 were referred for screening mammography. Gynecologists referred the greatest number of women for screening. An increase of mammography referrals was repeated by 81% of physicians; 21% of physicians stated that they referred all women over 50 for screening. Half of the physicians believed that women in their community were unaware of the benefits of mammography screening. Major deterrents were the cost of mammography and the lack of third-party coverage.

The epidemiological control of nematodes in New England lambs.

Epidemiological control of nematodes in weaned lambs in New England was investigated over three grazing seasons (n = 58, n = 52 and n = 62 lambs, respectively). Spring prophylactic treatment, clean pasture and mid-summer treat-and-move to hayfield strategies were compared to traditional fall treatments (control). In these studies when lambs were weaned prior to grazing, the most abundant nematodes were Nematodirus sp. Under these conditions, where only low levels of Haemonchus contortus were present, no significant improvement in body weight gain was observed for the epidemiologic approaches compared to the traditional fall treatments. No untreated control was used, and fecal egg counts and pasture larval counts indicate low total worm burdens with a controllable fall rise in pasture infectivity. These results indicate the importance of hypobiosis for the survival of H. contortus and suggest that weaning lambs prior to grazing can be an effective epidemiological control practice.

Efficacy of levamisole against immature and mature nematodes in goats with induced infections.

Anthelmintic efficacy of levamisole against induced infections with 7- and 21-day-old Haemonchus contortus, Ostertagia circumcincta, Trichostrongylus axei, and T colubriformis was evaluated as an oral drench in goats. Group 1 (n = 8) was not treated, group 2 (n = 8) was given 3.96 mg of levamisole/kg of body weight, group 3 (n = 8) was given 7.92 mg of levamisole/kg, and group 3 (n = 7) was given 11.88 mg of levamisole/kg. Efficacy against all worms was low in goats given 3.96 mg of levamisole/kg, but was high against adult H contortus (99%) and adult T colubriformis (99.7%) in goats given 7.92 mg of levamisole/kg. Although efficacy against adults of all species was high in goats given 11.88 mg of levamisole/kg, some immature worms of all species remained in the abomasa of goats.

Motility response of levamisole/benzimidazole-resistant Haemonchus contortus larvae.

Electronic measurements of the motility of third stage larvae of a susceptible and a levamisole/benzimidazole-resistant strain of Haemonchus contortus were made after incubation in solutions of anthelmintics for 24 h. Results confirmed the resistance to benzimidazoles, but failed to show differences in response to levamisole. Visual observations of paralysis of first and third stage larvae in solutions of levamisole also failed to show significant differences between the two strains. The tests as conducted failed to demonstrate levamisole resistance, suggesting that nematode strains may vary in their mechanisms of resistance to levamisole.

Selection of ivermectin-resistant Trichostrongylus colubriformis in lambs.

A mixed population of Haemonchus contortus, Teladorsagia circumcincta and Trichostrongylus colubriformis was passed for four generations through lambs. In successive passages and on Day 6 (D6), lambs were dosed subcutaneously with ivermectin at 100, 200, 250 and 225 micrograms kg-1 body weight, respectively. No larvae of H. contortus were recovered after the first passage and following the third drug exposure only T. colubriformis was present. Larvae of the selected strain of T. colubriformis developed to third stage, sheathed larvae in vitro in concentrations of ivermectin that inhibited development of larvae from the original strain of T. colubriformis. A definitive control test was then run with 45 lambs, to compare this selected strain to the original strain. The treatments were 150 micrograms kg-1 subcutaneous (SC) D6, 200 micrograms kg-1 SC D6, 200 micrograms kg-1 intraruminal (IR) D6 and 200 micrograms kg-1 SC D21; all treatments were compared to non-treated controls, selected or original strain as applicable. The D6 IR and D6 SC 150 micrograms kg-1 treatments were greater than 99% effective in both strains, although the D6 SC 200 micrograms kg-1 treatment was 85 and 48% effective in the original and selected strain, respectively. The D21 200 micrograms kg-1 was only 58% effective against the selected strain. There was significant (P less than 0.001) differences between the original and selected strains of T. colubriformis for both fecal egg output and worm counts. The exposure of four generations of immature T. colubriformis to ivermectin selected for partial resistance.

Larval development test for detection of anthelmintic resistant nematodes.

The growth, using freshly cultured Escherichia coli with ampicillin or heat-treated lyophilised E coli as a food source, of the larvae of the mouse nematode Nematospiroides dubius and the infectivity of resulting third stage larvae were determined. Concentrations of E coli between 0.5 and 1 mg dry weight ml-1 permitted optimal larval development for both N dubius and Trichostrongylus colubriformis. Development of larvae of susceptible and cambendazole-resistant strains of Haemonchus contortus in thiabendazole solutions showed clear differences between the strains and the larval development test was more sensitive than the egg hatch test. The test also detected a levamisole resistant strain of H contortus, although the degree of resistance could not be adequately measured. It is concluded that the test can be run with any anthelmintic to which resistance is suspected.

Use of anthelmintics by New England sheep producers.

Six hundred and sixty-five New England sheep producers responded to a postal survey on management practices, anthelmintic use, and the perceived failure of anthelmintics to control nematodes. Although the average farm had 34.8 lambs and 29.8 stock sheep, 59.8% and 50.3% of the total number of lambs and stock sheep were on 16.5% of the farms, which had greater than 50 lambs. About 54% of the lambs were born in January and February. Spring markets and confinement rearing were popular, as only 45.7% of the total lambs grazed summer pasture. Most producers (81.5%) treated their stock sheep (and lambs) for nematodiasis 2 to 4 times per year (mean, 3.3), generally before lambing, before pasturing, midsummer, and/or before breeding. Only 27.5% of the producers indicated distinct drenching management for grazing lambs. There was little use of preventive control, such as spring prophylaxis (0.5%) or dosing in midsummer and moving animals to safe pasture (2.9%). More than one anthelmintic class was used on 59.6% of the farms, with a mean of 1.88 anthelmintics per farm. Though 53.7% of the producers had a policy of alternating anthelmintic classes within a year, only 11.6% alternated anthelmintics annually. Levamisole and thiabendazole were the anthelmintics most frequently used by 81.8% and 61.6% of producers, respectively. However, 26.5% and 16.2% of the farms used fenbendazole and phenothiazine, respectively. The presence of gastrointestinal nematode resistance to anthelmintics was suggested, because 35.4% of the producers had discontinued using at least one anthelmintic that they considered to be ineffective. The anthelmintic that was most frequently discontinued was thiabendazole.(ABSTRACT TRUNCATED AT 250 WORDS)